Leishmaniasis News and Research

RSS
Leishmaniasis is a parasitic disease transmitted by the bite of infected sand flies. It is found in nearly 88 countries, from rain forests in Central and South America to deserts in the Middle East and west Asia. Some cases of the disease have also appeared in Mexico and Texas.

Leishmaniasis takes several different forms, including the most common cutaneous leishmaniasis, which causes skin sores, and the more severe visceral leishmaniasis, which affects internal organs such as the spleen, liver, and bone marrow. The World Health Organization (WHO) estimates that there are 1.5 million new cases of cutaneous leishmaniasis and 500,000 new cases of visceral leishmaniasis in the world each year.

Further Reading

Study reveals time-of-day impact on cerebral malaria severity

Study reveals time-of-day impact on cerebral malaria severity

ANU researchers develop cholesterol-based trojan horse method to target malaria parasites

ANU researchers develop cholesterol-based trojan horse method to target malaria parasites

Pioneering study brings leishmaniasis vaccine development closer

Pioneering study brings leishmaniasis vaccine development closer

Innovative dual-drug strategy for colorectal cancer treatment

Innovative dual-drug strategy for colorectal cancer treatment

How Aloe vera's medicinal properties make it essential in medicine, cosmetics, and food products

How Aloe vera's medicinal properties make it essential in medicine, cosmetics, and food products

New discovery could lead to a treatment for visceral leishmaniasis

New discovery could lead to a treatment for visceral leishmaniasis

WHO's new SkinNTD app proves effective in training healthcare workers for neglected tropical diseases

WHO's new SkinNTD app proves effective in training healthcare workers for neglected tropical diseases

Climate change threatens health in Europe: Urgent action needed to protect vulnerable populations

Climate change threatens health in Europe: Urgent action needed to protect vulnerable populations

New study reveals global risk distribution of visceral leishmaniasis

New study reveals global risk distribution of visceral leishmaniasis

Investigating IDO1 and PDL1: Key immune checkpoints in cutaneous leishmaniasis research

Investigating IDO1 and PDL1: Key immune checkpoints in cutaneous leishmaniasis research

Scientists uncover the mystery behind painless leishmaniasis lesions

Scientists uncover the mystery behind painless leishmaniasis lesions

Drug Discovery 2023: A Conversation with Professor Janet Hemingway

Drug Discovery 2023: A Conversation with Professor Janet Hemingway

Parasites that cause visceral leishmaniasis can infect non-immune cells, study finds

Parasites that cause visceral leishmaniasis can infect non-immune cells, study finds

Scientists delve deeper into how vaccines work against leishmaniasis

Scientists delve deeper into how vaccines work against leishmaniasis

Scientists discover mechanism of cell death in people living with HIV

Scientists discover mechanism of cell death in people living with HIV

Study identifies the predictors of post-coronavirus disease 2019 (COVID-19) syndrome symptoms

Study identifies the predictors of post-coronavirus disease 2019 (COVID-19) syndrome symptoms

UCalgary researchers discover how Leishmania parasites hide within the body

UCalgary researchers discover how Leishmania parasites hide within the body

Understanding the molecular mechanisms responsible for antimony drug resistance in Leishmania parasites

Understanding the molecular mechanisms responsible for antimony drug resistance in Leishmania parasites

Study findings offer hope for the development of novel treatments for leishmaniasis

Study findings offer hope for the development of novel treatments for leishmaniasis

Advancing the development of vaccines through recombinant technology

Advancing the development of vaccines through recombinant technology

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.